# OnCo record insight-molecular-diagnostics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/insight-molecular-diagnostics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "insight-molecular-diagnostics" ;
  schema:name "Insight Molecular Diagnostics (formerly Oncocyte)"@en ;
  schema:description "Insight Molecular Diagnostics, the renamed Oncocyte, is a small listed company whose cancer tests read gene activity in tumours to predict who will respond to immunotherapy, alongside a larger business in transplant rejection blood tests."@en ;
  schema:url <https://onco.cc/companies/insight-molecular-diagnostics/>, <https://imdxinc.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://imdxinc.com/>, <https://investors.imdxinc.com/>, <https://investors.imdxinc.com/news-releases/2026/08-10-2026-210715920> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> .